US Stocks
/
Zentalis Pharmaceuticals, Inc. Share Price
Zentalis Pharmaceuticals, Inc. Share Price

Zentalis Pharmaceuticals, Inc. Share Price

NASDAQ: ZNTL | Micro Cap
$2.50
-$0.04 (-1.76%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Zentalis Pharmaceuticals, Inc. Stock Performance

Open
$2.48
Prev. Close
$2.55
Circuit Range
N/A
Day Range
$2.39 - $2.53
Year Range
$1.22 - $6.94
Volume
48,076
Average Traded
$2.47

Zentalis Pharmaceuticals, Inc. Share Price Today

As of 9 October 2026, Zentalis Pharmaceuticals, Inc.'s share price is $2.50. The stock opened at $2.48, compared to its previous close of $2.55. During today's trading session, Zentalis Pharmaceuticals, Inc.'s share price traded between $2.39 and $2.53, with an average price of $2.46. Over the past 52 weeks, the stock has recorded a high of $6.94 and a low of $1.22. In terms of performance, Zentalis Pharmaceuticals, Inc.'s share price has declined by 37.45% over the last six months and is up 68.12% on a year-on-year basis.

Zentalis Pharmaceuticals, Inc. Share Price Chart

$2.39$2.53
L
Show Current Price
H

Zentalis Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$180.03M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.47
Revenue (TTM)
$0.00
Return On Equity (TTM)
-97.15%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-58.45%

Zentalis Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$26.69-$35.22-$35.35-$42.29
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-31.96%-0.37%-19.63%

Zentalis Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$67.43$0.00
Net Profit-$236.81-$292.19-$165.84-$137.06
Net Profit MarginN/AN/A-245.94%N/A
Income ChangeN/A-23.39%43.24%17.35%

About Zentalis Pharmaceuticals, Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Zentalis Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.74
$2.51
-8.89%
Sep 2026
$3.70
$2.75
-28.90%
Aug 2026
$4.66
$3.88
-18.16%
Jul 2026
$4.79
$4.74
-2.27%
Jun 2026
$3.99
$4.84
+21.12%
May 2026
$4.00
$4.00
-0.12%
Apr 2026
$2.43
$4.00
+70.43%
Mar 2026
$2.44
$2.35
-1.67%
Feb 2026
$2.42
$2.39
-2.05%
Jan 2026
$1.33
$2.44
+81.41%
Dec 2025
$1.39
$1.34
-5.94%
Nov 2025
$1.54
$1.43
-4.03%

ZNTL Share Price FAQs

What is Zentalis Pharmaceuticals, Inc. share price today?

chevron-up
Zentalis Pharmaceuticals, Inc. share price today is $2.50 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Zentalis Pharmaceuticals, Inc. stock?

chevron-up
The 52 week high of Zentalis Pharmaceuticals, Inc. stock is $6.94, while the 52 week low is $1.22 as of 9 Oct '26.

What is ZNTL's market capitalisation today?

chevron-up
ZNTL market capitalisation is $180.03M as of October 9, 2026, at 4:49 pm IST.

What is ZNTL's net income for the last quarter?

chevron-up
ZNTL's net income for the last quarter is -42.29B USD.

What is the 5 year returns of ZNTL?

chevron-up
The 5 year returns of ZNTL is -96.89% as on 9 Oct '26.

What is the high & low stock price of ZNTL today?

chevron-up
ZNTL stock price hit a high of $2.53 and low of $2.39 as of 9 Oct '26.

Can I buy ZNTL shares in India?

chevron-up
Yes. You can buy ZNTL in India by opening an international trading account.